Co-Diagnostics Stock (NASDAQ:CODX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.17

52W Range

$1.00 - $2.23

50D Avg

$1.25

200D Avg

$1.23

Market Cap

$35.44M

Avg Vol (3M)

$250.55K

Beta

-0.85

Div Yield

-

CODX Company Profile


Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

155

IPO Date

Jul 12, 2017

Website

CODX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23
Product Revenue$991.47K

Fiscal year ends in Dec 23 | Currency in USD

CODX Financial Summary


Dec 23Dec 22Dec 21
Revenue$6.81M$34.22M$97.89M
Operating Income$-42.71M$-11.59M$46.06M
Net Income$-35.33M$-14.24M$36.66M
EBITDA$-36.88M$-2.68M$46.44M
Basic EPS$-1.20$-0.45$1.27
Diluted EPS$-1.20$-0.45$1.23

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 07, 24 | 8:49 PM
Q2 24Aug 10, 24 | 11:14 AM
Q1 24May 09, 24 | 12:00 AM

Peer Comparison


TickerCompany
NURONeuroMetrix, Inc.
BMRABiomerica, Inc.
RPIDRapid Micro Biosystems, Inc.
INVOINVO Bioscience, Inc.
TIVCTivic Health Systems, Inc.
NVNOenVVeno Medical Corporation
MOVEMovano Inc.
CLPTClearPoint Neuro, Inc.
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
IINNInspira Technologies Oxy B.H.N. Ltd.
OPGNOpGen, Inc.
RSLSReShape Lifesciences Inc.
BBLGBone Biologics Corporation
BJDXBluejay Diagnostics, Inc.
HSCSHeart Test Laboratories, Inc.
INGNInogen, Inc.
CVRXCVRx, Inc.
VVOSVivos Therapeutics, Inc.
NAOVNanoVibronix, Inc.